KRMD
Price
$3.96
Change
-$0.04 (-1.00%)
Updated
Jan 10 closing price
Capitalization
107.88M
46 days until earnings call
NEOG
Price
$12.36
Change
-$0.71 (-5.43%)
Updated
Jan 10 closing price
Capitalization
3.42B
80 days until earnings call
Ad is loading...

KRMD vs NEOG

Header iconKRMD vs NEOG Comparison
Open Charts KRMD vs NEOGBanner chart's image
KORU Medical Systems
Price$3.96
Change-$0.04 (-1.00%)
Volume$26.49K
Capitalization107.88M
Neogen
Price$12.36
Change-$0.71 (-5.43%)
Volume$7.06M
Capitalization3.42B
KRMD vs NEOG Comparison Chart
Loading...
KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRMD vs. NEOG commentary
Jan 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRMD is a Hold and NEOG is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 12, 2025
Stock price -- (KRMD: $3.96 vs. NEOG: $12.36)
Brand notoriety: KRMD and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: KRMD: 34% vs. NEOG: 338%
Market capitalization -- KRMD: $107.88M vs. NEOG: $3.42B
KRMD [@Medical Specialties] is valued at $107.88M. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRMD’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • KRMD’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, KRMD is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRMD’s TA Score shows that 3 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • KRMD’s TA Score: 3 bullish, 4 bearish.
  • NEOG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than KRMD.

Price Growth

KRMD (@Medical Specialties) experienced а +1.54% price change this week, while NEOG (@Medical Specialties) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.46%. For the same industry, the average monthly price growth was -0.25%, and the average quarterly price growth was -0.18%.

Reported Earning Dates

KRMD is expected to report earnings on Apr 30, 2025.

NEOG is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Medical Specialties (-1.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEOG($3.42B) has a higher market cap than KRMD($108M). KRMD YTD gains are higher at: 2.857 vs. NEOG (1.812). NEOG has higher annual earnings (EBITDA): 189M vs. KRMD (-9.4M). NEOG has more cash in the bank: 230M vs. KRMD (11.5M). KRMD has less debt than NEOG: KRMD (4.45M) vs NEOG (889M). NEOG has higher revenues than KRMD: NEOG (919M) vs KRMD (28.5M).
KRMDNEOGKRMD / NEOG
Capitalization108M3.42B3%
EBITDA-9.4M189M-5%
Gain YTD2.8571.812158%
P/E RatioN/A150.80-
Revenue28.5M919M3%
Total Cash11.5M230M5%
Total Debt4.45M889M1%
FUNDAMENTALS RATINGS
KRMD vs NEOG: Fundamental Ratings
KRMD
NEOG
OUTLOOK RATING
1..100
7415
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
3776
P/E GROWTH RATING
1..100
473
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRMD's Valuation (93) in the null industry is in the same range as NEOG (96) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to NEOG’s over the last 12 months.

KRMD's Profit vs Risk Rating (100) in the null industry is in the same range as NEOG (100) in the Medical Specialties industry. This means that KRMD’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's SMR Rating (90) in the Medical Specialties industry is in the same range as KRMD (97) in the null industry. This means that NEOG’s stock grew similarly to KRMD’s over the last 12 months.

KRMD's Price Growth Rating (37) in the null industry is somewhat better than the same rating for NEOG (76) in the Medical Specialties industry. This means that KRMD’s stock grew somewhat faster than NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for KRMD (47) in the null industry. This means that NEOG’s stock grew somewhat faster than KRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRMDNEOG
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
66%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
72%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVKRF0.02N/A
+5.32%
GRID BATTERY METALS INC.
RYCEY7.05-0.07
-0.98%
Rolls Royce Holdings plc
MONDY28.50-0.46
-1.59%
Mondi Plc.
NPSCY6.48-0.20
-2.99%
Nippon Steel Corporation
NNOMF0.66-0.02
-3.16%
Nano One Materials Corp.

KRMD and

Correlation & Price change

A.I.dvisor tells us that KRMD and MASS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KRMD and MASS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
-1.00%
MASS - KRMD
29%
Poorly correlated
+11.88%
NVST - KRMD
28%
Poorly correlated
-3.08%
ARAY - KRMD
28%
Poorly correlated
+0.47%
CLPT - KRMD
27%
Poorly correlated
-2.59%
OM - KRMD
26%
Poorly correlated
-5.83%
More

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with CRL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
-5.43%
CRL - NEOG
44%
Loosely correlated
-0.95%
ICUI - NEOG
41%
Loosely correlated
-4.12%
MASS - NEOG
41%
Loosely correlated
+11.88%
TWST - NEOG
40%
Loosely correlated
-3.37%
RVTY - NEOG
39%
Loosely correlated
-2.18%
More